SFX by Ex Libris Inc.

Title:	Assignment of the Human Growth Hormone-Releasing Hormone Receptor Gene (GHRHR) to 7p14 by in Situ Hybridization
Source:	Genomics [0888-7543] Gaylinn, Bruce yr:1994

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Azim, H. "Targeting mTOR in cancer: renal cell is just a beginning." Targeted oncology 5.4 (2010): 269-280.
description	2.	Meek, S.E.M. M. "Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins." The Journal of biological chemistry 279.31 (2004): 32046-32054.
description	3.	Mattei, M G G. "Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively." Genomics 40.1 (1997): 168-9.
description	4.	Zou, Y. "Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis." Breast cancer research 10.1 (2008).
description	5.	Hay, N. "Upstream and downstream of mTOR." Genes & development 18.16 (2004): 1926-45.
description	6.	Huang, J. "The TSC1-TSC2 complex: a molecular switchboard controlling cell growth." The Biochemical journal 412.Part 2 (2008): 179-90.
description	7.	Sarbassov, Dos D D. "Growing roles for the mTOR pathway." Current opinion in cell biology 17.6: 596-603.
description	8.	Guertin, David M A. "Defining the role of mTOR in cancer." Cancer cell 12.1 (2007): 9-22.
description	9.	Bjornsti, Mary-Ann A. "The TOR pathway: a target for cancer therapy." Nature reviews. Cancer 4.5 (2004): 335-48.
description	10.	Ruggero, D.. "Does the ribosome translate cancer?" Nature reviews. Cancer 3.3 (2003): 179-192.
description	11.	Schmelzle, T. "TOR, a central controller of cell growth." Cell 103.2 (2000): 253-262.
description	12.	Yaffe, M. "How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis." FEBS letters 513.1 (2002): 53-57.
description	13.	"STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling." Scientific reports. 6.1: 33205-33205.
description	14.	Desplans, D. "cAMP-dependent protein kinase from Plasmodium falciparum: an update." Parasitology 138.1 (2011): 1-25.
description	15.	Carnevalli, Larissa S. "S6K1 plays a critical role in early adipocyte differentiation." Developmental cell 18.5 (2010): 763-774.
description	16.	Yip, Seong K. "Structure of the human mTOR complex I and its implications for rapamycin inhibition." Molecular cell 38.5 (2010): 768-774.
description	17.	Benzinger, A.. "Targeted proteomic analysis of 14-3-3σ, a p53 effector commonly silenced in cancer." Molecular & cellular proteomics 4.6 (2005): 785-795.
description	18.	Maertens, G. "Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75." The Journal of biological chemistry 279.32 (2004): 33421-9.
description	19.	Kinoh, H. "Assignment of the genes for membrane-type-4 matrix metalloproteinase (Mmp17, MMP17) to mouse chromosome 5, human chromosome band 12q24.3 and membrane-type-5 matrix metalloproteinase (Mmp24, MMP24) to mouse chromosome 2 and human chromosome band 20q11.2-->." Cytogenetics and cell genetics (1999): 97-8.
description	20.	Hadchouel, A. "Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development." PloS one 3.9 (2008).